uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Urorec
Authorised
Human
Details
EMA number
EMEA/H/C/001092
ATC code
G04CA04
Authorisation
29 January 2010
Revision
20
EMA page
Therapeutic indication
Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
MeSH:
Prostatic Hyperplasia
Group:
Urologicals
Active substances
silodosin
Marketing Authorisation Holder
Recordati Ireland Ltd
MAH
Timeline
Filter by authority:
EMA
Urorec authorised
29 Jan 2010
authorised
regulatory
Urorec | uMedical